Reduced eukaryotic initiation factor 2Bε-subunit expression suppresses the transformed phenotype of cells overexpressing the protein

Cancer Research

Volumn 68, Issue 21, 2008, Pages 8752-8760

  Gallagher, James W ^a   Kubica, Neil ^b   Kimball, Scot R ^a   Jefferson, Leonard S ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EUKARYOTIC INITIATION FACTOR 2B EPSILON; GUANINE NUCLEOTIDE EXCHANGE FACTOR; MESSENGER RNA; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

AGAR MEDIUM; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CANCER CELL; CANCER THERAPY; CARCINOGENIC ACTIVITY; CELL GROWTH; CELL LINE; CELL STRAIN HEK293; CELL STRAIN MCF 7; CELL TRANSFORMATION; COLONY FORMATION; CONTROLLED STUDY; EMBRYO; FIBROBLAST; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; GROWTH RATE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; RNA TRANSLATION; TARGET CELL; TRANSIENT TRANSFECTION; TUMOR CELL; TUMOR GROWTH; UPREGULATION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; BASE SEQUENCE; CELL LINE, TRANSFORMED; EUKARYOTIC INITIATION FACTOR-2; HUMANS; MICE; MICE, NUDE; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 55349092971     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-1042     Document Type: Article

References (50)

1. Erickson FL, Hannig EM. Ligand interactions with eukaryotic translation initiation factor 2: role of the γ-subunit. EMBO J 1996;15:6311-20.
2. Rowlands AG, Panniers R, Henshaw EC. The catalytic mechanism of guanine nucleotide exchange factor action and competitive inhibition by phosphorylated eukaryotic initiation factor 2. J Biol Chem 1988;263:5526-33.
3. Wang X, Janmaat M, Beugnet A, Paulin FE, Proud CG. Evidence that the dephosphorylation of Ser(535) in the ε-subunit of eukaryotic initiation factor (eIF) 2B is insufficient for the activation of eIF2B by insulin. Biochem J 2002;367:475-81.
4. Welsh GI, Miller CM, Loughlin AJ, Price NT, Proud CG. Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin. FEBS Lett 1998;421:125-30.
5. Woods YL, Cohen P, Becker W, et al. The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bε at Ser539 and the microtubule-associated protein τ at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase. Biochem J 2001;355:609-15.
6. Pavitt GD, Ramaiah KVA, Kimball SR, Hinnebusch AG. eIF2 independently binds two distinct eIF2B subcomplexes that catalyze and regulate guanine-nucleotide exchange. Genes Dev 1998;12:514-26.
7. Fabian JR, Kimball SR, Jefferson LS. Reconstitution and purification of eukaryotic initiation factor 2B (eIF2B) expressed in Sf21 insect cells. Protein Expr Purif 1998;13:16-22.
8. Fabian JR, Kimball SR, Heinzinger ND, Jefferson LS. Subunit assembly and guanine nucleotide exchange activity of eukaryotic initiation factor-2B (eIF-2B) expressed in Sf9 cells. J Biol Chem 1997;272:12359-65.
9. Yang W, Hinnebusch AG. Identification of a regulatory subcomplex in the guanine nucleotide exchange factor eIF2B that mediates inhibition by phosphorylated eIF2. Mol Cell Biol 1996;16:6603-16.
10. Kimball SR, Heinzinger NK, Horetsky RL, Jefferson LS. Identification of interprotein interactions between the subunits of eukaryotic initiation factors eIF2 and eIF2B. J Biol Chem 1998;273:3039-44.
11. Hannig EM, Williams NP, Wek RC, Hinnebusch AG. The translational activator GCN3 functions downstream from GCN1 and GCN2 in the regulatory pathway that couples GCN4 expression to amino acid availability in Saccharomyces cerevisiae. Genetics 1990;126:549-62.
12. Raught B, Gingras AC, James A, Medina D, Sonenberg N, Rosen JM. Expression of a translationally regulated, dominant-negative CCAAT/enhancer-binding protein β isoform and up-regulation of the eukaryotic translation initiation factor 2α are correlated with neoplastic transformation of mammary epithelial cells. Cancer Res 1996;56:4382-6.
13. Balachandran S, Barber GN. Defective translational control facilitates vesicular stomatitis virus oncolysis. Cancer Cell 2004;5:51-65.
14. Yoshizawa F, Kimball SR, Jefferson LS. Modulation of translation initiation in rat skeletal muscle and liver in response to food intake. Biochem Biophys Res Commun 1997;240:825-31.
15. Kimball SR, Everson WV, Myers LM, Jefferson LS. Purification and characterization of eukaryotic initiation factor 2 and a guanine nucleotide exchange factor from rat liver. J Biol Chem 1987;262:2220-7.
16. Stewart SA, Dykxhoorn DM, Palliser D, et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 2003;9:493-501.
17. Wright JL, Jordan M, Wurm FM. Transfection of partially purified plasmid DNA for high level transient protein expression in HEK293-EBNA cells. J Biotechnol 2003;102:211-21.
18. Farrell PA, Fedele MJ, Vary TC, Kimball SR, Lang CH, Jefferson LS. Regulation of protein synthesis after acute resistance exercise in diabetic rats. Am J Physiol Endocrinol Metab 1999;276:E721-7.
19. Kimball SR, Jefferson LS. Effect of diabetes on guanine nucleotide exchange factor activity in skeletal muscle and heart. Biochem Biophys Res Commun 1988;156:706-11.
20. Kim SH, Forman AP, Mathews MB, Gunnery S. Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR. Oncogene 2000;19:3086-94.
21. Sudhakar A, Ramachandran A, Ghosh S, Hasnain SE, Kaufman RJ, Ramaiah KV. Phosphorylation of serine 51 in initiation factor 2α (eIF2α) promotes complex formation between eIF2α(P) and eIF2B and causes inhibition in the guanine nucleotide exchange activity of eIF2B. Biochemistry 2000;39:12929-38.
22. Chen J, Bander JA, Santore TA, et al. Expression of Q227L-Gαs in MCF-7 human breast cancer cells inhibits tumorigenesis. Proc Natl Acad Sci U S A 1998;95:2648-52.
23. Hwang RF, Moore T, Arumugam T, et al. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 2008;68:918-26.
24. Tao WJ, Lin H, Sun T, Samanta AK, Arlinghaus R. BCR-ABL oncogenic transformation of NIH 3T3 fibroblasts requires the IL-3 receptor. Oncogene 2007;27:3194-200.
25. Culjkovic B, Topisirovic I, Borden KLB. Controlling gene expression through RNA regulons: the role of the eukaryotic initiation factor eIF4E. Cell Cycle 2007;6:65-9.
26. De Benedetti A, Graff JR. eIF-4E expression and its role in malignancies and metastases. Oncogene 2004;23:3189-99.
27. De Benedetti A, Rhoads RE. Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. Proc Natl Acad Sci U S A 1990;87:8212-6.
28. De Benedetti A, Joshi B, Graff JR, Zimmer SG. CHO cells transformed by the translation factor eIF4E display increased c-myc expression but require overexpression of Max for tumorigenicity. Mol Cell Differ 1994;2:347-71.
29. Lazaris-Karatzas A, Montine KS, Sonenberg N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature 1990;345:544-7.
30. Lazaris-Karatzas A, Smith MR, Frederickson RM, et al. Ras mediates translational initiation factor 4E-induced malignant transformation. Genes Dev 1992;6:1631-42.
31. Bauer C, Diesinger I, Brass N, Steinhart H, Iro H, Meese EU. Translation initiation factor eIF-4G is immunogenic, overexpressed, and amplified in patients with squamous cell lung carcinoma. Cancer 2001;92:822-9.
32. Brass N, Heckel D, Sahin U, Pfreundschuh M, Sybrecht GW, Meese E. Translation initiation factor eIF-4γ is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma. Hum Mol Genet 1997;6:33-9.
33. Eberle J, Krasagakis K, Orfanos CE. Translation initiation factor eIF-4A1 mRNA is consistently overexpressed in human melanoma cells in vitro. Int J Cancer 1997;71:396-401.
34. Fukuchi-Shimogori T, Ishii I, Kashiwagi K, Mashiba H, Ekimoto H, Igarashi K. Malignant transformation by overproduction of translation initiation factor eIF4G. Cancer Res 1997;57:5041-4.
35. Lynch M, Fitzgerald C, Johnston KA, Wang S, Schmidt EV. Activated eIF4E-binding protein slows G1 progression and blocks transformation by c-myc without inhibiting cell growth. J Biol Chem 2004;279:3327-39.
36. Rousseau D, Gingras A-C, Pause A, Sonenberg N. The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth. Oncogene 1996;13:2415-20.
37. Graff JR, Konicek BW, Vincent TM, et al. Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity. J Clin Invest 2007;117:2638-48.
38. Raught B, Gingras A-C, James A, Medina D, Sonenberg N, Rosen JM. Expression of a translationally regulated, dominant-negative CCAAT/enhancer-binding protein β isoform and up-regulation of the eukaryotic translation initiation factor 2α are correlated with neoplastic transformation of mammary epithelial cells. Cancer Res 1996;56:4382-6.
39. Wang S, Rosenwald IB, Hutzler MJ, et al. Expression of the eukaryotic translation initiation factors 4E and 2α in non-Hodgkin's lymphomas. Am J Pathol 1999;155:247-55.
40. Rosenwald IB, Rhoads DB, Callanan LD, Isselbacher KJ, Schmidt EV. Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2α in response to growth induction by c-myc. Proc Natl Acad Sci U S A 1993;90:6175-8.
41. Rosenwald IB. Upregulated expression of the genes encoding translation initiation factors eIF-4E and eIF-2α in transformed cells. Cancer Lett 1996;102:113-23.
42. Donzé O, Jagus R, Koromilas AE, Hershey JWB, Sonenberg N. Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J 1995;14:3828-34.
43. Koromilas AE, Roy S, Barber GN, Katze MG, Sonenberg N. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein Kinase. Science 1992;257:1685-9.
44. Meurs EF, Galabru J, Barber GN, Katze MG, Hovanessian AG. Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc Natl Acad Sci U S A 1993;90:232-6.
45. Barber GN, Thompson S, Lee TG, et al. The 58-kilodalton inhibitor of the interferon-induced double-stranded RNA activated protein kinase is a tetra-tricopeptide repeat protein with oncogenic properties. Proc Natl Acad Sci U S A 1994;91:4278-82.
46. Lu PD, Harding HP, Ron D. Translation reinitiation at alternative open reading frames regulates gene expression in an integrated stress response. J Cell Biol 2004;167:27-33.
47. Zhou D, Palam LR, Jiang L, Narasimhan J, Staschke KA, Wek RC. Phosphorylation of eIF2 directs ATF5 translational control in response to diverse stress conditions. J Biol Chem 2008;283:7064-73.
48. Casanova JE. Regulation of Arf activation: the Sec7 family of guanine nucleotide exchange factors. Traffic 2007;8:1476-85.
49. Garcia-Mata R, Burridge K. Catching a GEF by its tail. Trends Cell Biol 2007;17:36-43.
50. Quilliam LA, Rebhun JF, Castro AF. A growing family of guanine nucleotide exchange factors is responsible for activation of Ras-family GTPases. Prog Nucleic Acid Res Mol Biol 2002;71:391-444.